Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

by Webmaster | Dec 9, 2022 | News, Press Release, Resources, Treatment

Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis

by The Pericarditis Alliance | Jun 6, 2022 | Education, Journal, Resources, Treatment

Cardiol Therapeutics Announces FDA Investigational New Drug Application…

by The Pericarditis Alliance | May 18, 2022 | Press Release, Resources, Treatment

Kiniksa Announces FDA Approval of Arcalyst

by Dona Winnowski | Aug 14, 2021 | Press Release, Resources, Treatment

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

by Dona Winnowski | Jul 14, 2021 | Education, Journal, Resources, Treatment

KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS

by Dona Winnowski | Mar 18, 2021 | Press Release, Resources, Treatment